Sustained Codelivery of Cisplatin and Paclitaxel via an Injectable Prodrug Hydrogel for Ovarian Cancer Treatment
The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
The sustained release of both the hydrophilic drug and hydrophobic drug from one delivery system remains challenging in pharmaceutics and biomaterials science. The combination of hydrophilic cisplatin and hydrophobic paclitaxel (PTX) exhibits a clinical survival advantage compared with the individual drug therapy against various tumors such as ovarian cancer. In this study, a localized, long-term codelivery system of cisplatin and PTX was developed using an injectable and thermosensitive polymer-platinum(IV) conjugate hydrogel as the carrier. The thermosensitive Bi(mPEG-PLGA)-Pt(IV) (PtGel) conjugate was synthesized via covalently linking two mPEG-PLGA copolymers onto a Pt(IV) prodrug, and its concentrated aqueous solution exhibited a reversible sol-gel transition upon heating. Meanwhile, the core-corona micelles formed by the amphiphilic conjugates in water could serve as a reservoir for the solubilization of PTX, and thus an injectable binary drug-loaded hydrogel formulation was obtained. We also found that the introduction of PTX into the conjugate hydrogel decreased its sol-gel transition temperature and improved its gel strength. In vitro release experiments showed that both of the loaded drugs were released in a sustained manner for as long as 2.5 months, which was the longest combination delivery of these two drugs ever reported. In vitro cellular assays revealed that the dual-drug system exhibited a synergistic anticancer effect against ovarian cancer cells. Finally, using the SKOV-3 ovarian cancer xenograft mouse model, we demonstrated that a single injection of the PTX-loaded conjugate hydrogel system resulted in enhanced anticancer efficacy and significantly reduced the side effects, when compared with the multiple injections of the free drug combination.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several prior studies have reported the nanoformulations simultaneously containing PTX and cisplatin, including formulations based on polymeric micelles formed by amphiphilic block copolymers [26–28], mesoporous carbon-silica nanospheres [29], and prodrug hydrogels [30].”
Citations
Cites
Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178
Kinetic modeling on drug release from controlled drug delivery systems.
Dash, S., Murthy, P. N., Nath, L., & Chowdhury, P. (2010) · PubMed · Cited by 2,733
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Armstrong, D. K., Bundy, B., Wenzel, L., Huang, H. Q., Baergen, R., Lele, S., Copeland, L. J., Walker, J. L., & Burger, R. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052985 · Cited by 2,625
Injectable hydrogels as unique biomedical materials
Yu, L., & Ding, J. (2008) · Chemical Society Reviews · doi:10.1039/b713009k · Cited by 1,545
Self-citationDirect Cellular Responses to Platinum-Induced DNA Damage
Jung, Y., & Lippard, S. J. (2007) · Chemical Reviews · doi:10.1021/cr068207j · Cited by 1,391
Paclitaxel and its formulations
Singla, A. K., Garg, A., & Aggarwal, D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00986-3 · Cited by 1,100
Hydrogels for Protein Delivery
Vermonden, T., Censi, R., & Hennink, W. E. (2012) · Chemical Reviews · doi:10.1021/cr200157d · Cited by 1,091
Synergistic drug combinations tend to improve therapeutically relevant selectivity
Lehár, J., Krueger, A. S., Avery, W., Heilbut, A. M., Johansen, L. M., Price, E. R., Rickles, R. J., Short III, G. F., Staunton, J. E., Jin, X., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1549 · Cited by 938
Greco, F., & Vicent, M. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.006 · Cited by 652
Kolishetti, N., Dhar, S., Valencia, P. M., Lin, L. Q., Karnik, R., Lippard, S. J., Langer, R., & Farokhzad, O. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011368107 · Cited by 565
Hydrogels for Therapeutic Delivery: Current Developments and Future Directions
Buwalda, S. J., Vermonden, T., & Hennink, W. E. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.6b01604 · Cited by 497
Temperature-responsive compounds as in situ gelling biomedical materials
Moon, H. J., Ko, D. Y., Park, M. H., Joo, M. K., & Jeong, B. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35078e · Cited by 421
Polymer−Cisplatin Conjugate Nanoparticles for Acid-Responsive Drug Delivery
Aryal, S., Hu, C.-M. J., & Zhang, L. (2010) · ACS Nano · doi:10.1021/nn9014032 · Cited by 400
Cisplatin Binding Sites on Human Albumin
Ivanov, A. I., Christodoulou, J., Parkinson, J. A., Barnham, K. J., Tucker, A., Woodrow, J., & Sadler, P. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.14721 · Cited by 362
Stimuli-sensitive nanopreparations for combination cancer therapy
Jhaveri, A., Deshpande, P., & Torchilin, V. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.002 · Cited by 334
Detouring of cisplatin to access mitochondrial genome for overcoming resistance
Marrache, S., Pathak, R. K., & Dhar, S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405244111 · Cited by 245
Co-delivery of chemotherapeutics and proteins for synergistic therapy
He, C., Tang, Z., Tian, H., & Chen, X. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.021 · Cited by 231
Self-citationXiao, H., Song, H., Yang, Q., Cai, H., Qi, R., Yan, L., Liu, S., Zheng, Y., Huang, Y., Liu, T., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.05.049 · Cited by 200
Xu, X., Huang, Z., Huang, Z., Zhang, X., He, S., Sun, X., Shen, Y., Yan, M., & Zhao, C. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b02307 · Cited by 192
Biodegradable polymer − cisplatin(IV) conjugate as a pro-drug of cisplatin(II)
Xiao, H., Qi, R., Liu, S., Hu, X., Duan, T., Zheng, Y., Huang, Y., & Jing, X. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.06.072 · Cited by 187
Wu, X., He, C., Wu, Y., & Chen, X. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.10.016 · Cited by 186
Self-citationPEG- b -PLA micelles and PLGA- b -PEG- b -PLGA sol–gels for drug delivery
Cho, H., Gao, J., & Kwon, G. S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.015 · Cited by 186
Zhang, Z.-Q., & Song, S.-C. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.08.015 · Cited by 170
Ma, H., He, C., Cheng, Y., Li, D., Gong, Y., Liu, J., Tian, H., & Chen, X. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.06.045 · Cited by 160
Self-citationCai, L., Xu, G., Shi, C., Guo, D., Wang, X., & Luo, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.044 · Cited by 151
Ma, H., He, C., Cheng, Y., Yang, Z., Zang, J., Liu, J., & Chen, X. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b09112 · Cited by 150
Self-citationSeo, B., Koh, J., & Song, S. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.01.016 · Cited by 139
Qu, Y., Chu, B. Y., Peng, J. R., Liao, J. F., Qi, T. T., Shi, K., Zhang, X. N., Wei, Y. Q., & Qian, Z. Y. (2015) · NPG Asia Materials · doi:10.1038/am.2015.83 · Cited by 136
Liu, B., Han, L., Liu, J., Han, S., Chen, Z., & Jiang, L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s115136 · Cited by 129
Yoong, S. L., Wong, B. S., Zhou, Q., Chin, C. F., Li, J., Venkatesan, T., Ho, H. K., Yu, V. C. K., Ang, W. H., & Pastorin, G. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.036 · Cited by 123
Stathopoulos, G. P., Antoniou, D., Dimitroulis, J., Michalopoulou, P., Bastas, A., Marosis, K., Stathopoulos, J., Provata, A., Yiamboudakis, P., Veldekis, D., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq234 · Cited by 123
PHB‐Based Gels as Delivery Agents of Chemotherapeutics for the Effective Shrinkage of Tumors
Wu, Y., Wang, H., Qiu, Y., Liow, S. S., Li, Z., & Loh, X. J. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600723 · Cited by 113
Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer
Desale, S. S., Cohen, S. M., Zhao, Y., Kabanov, A. V., & Bronich, T. K. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.026 · Cited by 110
Chen, L., Ci, T., Yu, L., & Ding, J. (2015) · Macromolecules · doi:10.1021/acs.macromol.5b00168 · Cited by 109
Self-citationSustained intravitreal delivery of dexamethasone using an injectable and biodegradable thermogel
Zhang, L., Shen, W., Luan, J., Yang, D., Wei, G., Yu, L., Lu, W., & Ding, J. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.05.005 · Cited by 106
Self-citationThermogelling Polymer–Platinum(IV) Conjugates for Long-Term Delivery of Cisplatin
Shen, W., Luan, J., Cao, L., Sun, J., Yu, L., & Ding, J. (2015) · Biomacromolecules · doi:10.1021/bm501220a · Cited by 103
Self-citationJones, N. A., Turner, J., McIlwrath, A. J., Brown, R. E., & Dive, C. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13247-6 · Cited by 102
Petit, A., Sandker, M., Müller, B. M., Meyboom, R., van Midwoud, P. M., de Bruin, P., Redout, E. M., Versluijs‐Helder, M., van de Lest, C. H. A., Buwalda, S. J., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.064 · Cited by 102
Controlled release of liraglutide using thermogelling polymers in treatment of diabetes
Chen, Y., Li, Y., Shen, W., Li, K., Yu, L., Chen, Q., & Ding, J. (2016) · Scientific Reports · doi:10.1038/srep31593 · Cited by 97
Self-citationInjectable and Thermosensitive Hydrogel Containing Liraglutide as a Long-Acting Antidiabetic System
Chen, Y., Luan, J., Shen, W., Lei, K., Yu, L., & Ding, J. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b09415 · Cited by 95
Self-citationYang, J. J., Liu, W., Sui, M., Tang, J., & Shen, Y. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.022 · Cited by 93
Lee, Y., Choi, K., Park, K. M., Lee, J., Park, B. J., & Park, K. D. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b03870 · Cited by 93
Wang, W., Deng, L., Liu, S., Li, X., Zhao, X., Hu, R., Zhang, J., Han, H., & Dong, A. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.07.021 · Cited by 89
Moore, K. N., Herzog, T. J., Lewin, S. N., Giuntoli, R. L., Armstrong, D. K., Rocconi, R. P., Spannuth, W. A., & Gold, M. A. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.12.031 · Cited by 85
Nanoparticle-Mediated Mitochondrial Damage Induces Apoptosis in Cancer
Mallick, A., More, P. A., Syed, M. M. K., & Basu, S. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b00263 · Cited by 81
Maximizing Synergistic Activity When Combining RNAi and Platinum-Based Anticancer Agents
Xiao, H., Qi, R., Li, T., Awuah, S. G., Zheng, Y., Wei, W., Kang, X., Song, H., Wang, Y., Yu, Y., et al. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b12108 · Cited by 81
Calcitonin-Loaded Thermosensitive Hydrogel for Long-Term Antiosteopenia Therapy
Liu, Y., Chen, X., Li, S., Guo, Q., Xie, J., Yu, L., Xu, X., Ding, C., Li, J., & Ding, J. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b05740 · Cited by 79
Self-citationWu, Z., Zou, X., Yang, L., Lin, S., Fan, J., Yang, B., Sun, X., Wan, Q., Chen, Y., & Fu, S. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.06.052 · Cited by 77
Wang, W., Liu, J., Li, C., Zhang, J., Liu, J., Dong, A., & Kong, D. (2014) · Journal of Materials Chemistry B · doi:10.1039/c4tb00275j · Cited by 71
Injectable intratumoral hydrogel as 5-fluorouracil drug depot
Seo, H. W., Kim, D. Y., Kwon, D. Y., Kwon, J. S., Jin, L. M., Lee, B. H., Kim, J. H., Min, B. H., & Kim, M. S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.006 · Cited by 71
Davoodi, P., Ng, W. C., Yan, W., Srinivasan, M. P., & Wang, C. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b03041 · Cited by 71
Cho, H., & Kwon, G. S. (2014) · Journal of Drug Targeting · doi:10.3109/1061186x.2014.931406 · Cited by 69
Huang, J., Zhou, Y., Zhang, H., Qu, T., Mao, Y., Zhu, H., Quan, L., Xing, P., Wang, J., He, J., et al. (2012) · Medical Oncology · doi:10.1007/s12032-012-0343-4 · Cited by 68
Petit, A., Redout, E. M., van de Lest, C. H. A., de Grauw, J. C., Müller, B. M., Meyboom, R., van Midwoud, P. M., Vermonden, T., Hennink, W. E., & van Weeren, P. R. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.109 · Cited by 66
Hong, J. H., Lee, H. J., & Jeong, B. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b02488 · Cited by 65
Vanhoefer, U. J., Harstrick, A., Wilke, H., Schleucher, N., Walles, H., Schröder, J., & Seeber, S. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(94)00440-g · Cited by 64
Targeted delivery of platinum-taxane combination therapy in ovarian cancer
Desale, S. S., Soni, K. S., Romanova, S., Cohen, S. M., & Bronich, T. K. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.007 · Cited by 61
Control of rhGH Release Profile from PEG–PAF Thermogel
Shinde, U. P., Moon, H. J., Ko, D. Y., Jung, B. K., & Jeong, B. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b00325 · Cited by 48
Matrices for combined delivery of proteins and synthetic molecules
Gilmore, K. A., Lampley, M. W., Boyer, C. A., & Harth, E. M. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.018 · Cited by 33
Davoodi, P., Ng, W. C., Srinivasan, M. P., & Wang, C. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26406 · Cited by 33
Levasseur, L. M., Greco, W. R., Rustum, Y. M., & Slocum, H. K. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050693 · Cited by 29
Hu, X., Wang, B., Sun, S., Tang, L., Zhang, J., Lv, F., Wang, Z., Wang, L., Zhang, Q., Zheng, C., et al. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s58275 · Cited by 25
Luan, J., Cui, S., Wang, J., Shen, W., Yu, L., & Ding, J. (2017) · Polymer Chemistry · doi:10.1039/c7py00232g · Cited by 22
Self-citationTang, L., Wang, B. Y., Sun, S., Zhang, J., Jia, Z., Lu, Y., Di, G.-H., Shao, Z. M., & Hu, X. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-232 · Cited by 15
Hayashi, T., Yoshizawa, M., Watanabe, N., Murayama, Y., & Shimizu, H. (2006) · PubMed · Cited by 2
Research works printed but not linked: 2
- Hayashi T., 2006, Gan to Kagaku Ryoho, 33, 1167
- Dash S., 2010, Acta Pol. Pharm., 67, 217
Cited by
Hydrogel-Based Controlled Drug Delivery for Cancer Treatment: A Review
Sun, Z., Song, C., Wang, C., Hu, Y., & Wu, J. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01020 · Cited by 413
Hydrogel design strategies for drug delivery
Dreiss, C. A. (2020) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2020.02.001 · Cited by 356
“codelivery of multiple drugs (4)(5)(6)(7), simultaneous imaging and therapy (8–10), programmable and controlled release (1,11,12), the hierarchy of micro- and nano-environments accessible (hydrophobic or hydrophilic), and a plethora of additional possibilities, such as attaching ligands, combining them with nanopartic…”
BackgroundPEG-based thermosensitive and biodegradable hydrogels
Shi, J., Yu, L., & Ding, J. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.04.009 · Cited by 341
Self-citationHu, C., Zhang, F., Long, L., Kong, Q., Luo, R., & Wang, Y. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.05.010 · Cited by 290
Recent advances in regenerative biomaterials
Cao, D., & Ding, J. (2022) · Regenerative Biomaterials · doi:10.1093/rb/rbac098 · Cited by 259
“[338–340]; prodrug micelles are capable of protecting API via covalently bonding an API to amphiphilic polymers [341, 342]; PEGylation, namely, covalently grafting a PEG polymer to a drug can enhance the therapeutic properties of API by prolongation of the drug circulation in plasma [343]; even simply mixing with PEG…”
Self-citation
Metadata
- Authors
- Shen, W., Chen, X., Luan, J., Wang, D., Yu, L., & Ding, J.
- Affiliations
- Fudan University (CN)
- Corresponding author
- Yu, Lin
- Venue
- ACS Applied Materials & Interfaces
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-11-13
- Volume
- 9
- Issue
- 46
- Pages
- 40031-40046
- ISSN
- 1944-8244 (ISSN-L)
- 1944-8252
- OpenAlex
- W2770498164
- Cited by
- 138
- References
- 65
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 8 · 2023: 17 · 2022: 15 · 2021: 20 · 2020: 17 · 2019: 21 · 2018: 16
- FWCI
- 5.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- ACS Applied Materials & Interfaces (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Science and Technology of the People's Republic of China (2016YFC1100300)
- National Natural Science Foundation of China (21474019, 51273217)
- Science and Technology Developing Foundation of Shanghai (15JC1490300)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- cisplatin, paclitaxel, ovarian cancer, co-delivery, injectable hydrogel, thermosensitive hydrogel, platinum(IV) prodrugs, sol-gel transition, sustained drug release, combination chemotherapy, synergistic antitumor effect, SKOV3 xenograft
- MeSH terms
- Animals, Cisplatin, Drug Carriers, Female, Micelles, Ovarian Neoplasms, Polyethylene Glycols, Prodrugs, Drug Delivery Systems, Paclitaxel, Hydrogels, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.